| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.642 | 23.273 | 10.676 | 11.329 | 7.753 | 2.700 |
| Total Income - EUR | - | - | - | - | 2.642 | 23.273 | 10.676 | 11.329 | 7.753 | 2.971 |
| Total Expenses - EUR | - | - | - | - | 4.081 | 18.101 | 12.500 | 9.489 | 7.192 | 3.863 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.439 | 5.172 | -1.824 | 1.840 | 561 | -891 |
| Net Profit/Loss - EUR | - | - | - | - | -1.519 | 4.481 | -2.106 | 1.517 | 484 | -891 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cbd Tratament S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 609 | 239 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 5.368 | 15.022 | 16.524 | 18.444 | 9.754 | 7.628 |
| Inventories | - | - | - | - | 3.290 | 12.566 | 15.539 | 15.039 | 3.620 | 3.631 |
| Receivables | - | - | - | - | 1.183 | 470 | 176 | 85 | 914 | 639 |
| Cash | - | - | - | - | 895 | 1.986 | 809 | 3.320 | 5.220 | 3.358 |
| Shareholders Funds | - | - | - | - | -1.477 | 3.032 | 859 | 2.379 | 2.856 | 1.949 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 7.454 | 12.229 | 15.666 | 16.065 | 6.898 | 5.680 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Cbd Tratament S.r.l.